Johnson & Johnson

NYSE

Market Cap.

375.12B

Avg. Volume

9.67M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Johnson & Johnson

Johnson & Johnson News

Johnson & Johnson Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareDrug Manufacturers - General
jnj.com

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson Earnings & Revenue

Johnson & Johnson Financials

Table Compare

Compare JNJ metrics with:

   

Earnings & Growth

JNJ

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

JNJ

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

JNJ

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

JNJ

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Johnson & Johnson Income

Johnson & Johnson Balance Sheet

Johnson & Johnson Cash Flow

Johnson & Johnson Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioNeutral
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Johnson & Johnson Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

5.0200

Payment DateDividendFrequency
2025-06-101.3Quarterly
2025-03-041.24Quarterly
2024-12-101.24Quarterly
2024-09-101.24Quarterly
2024-06-041.24Quarterly

Johnson & Johnson Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Johnson & Johnson Executives

NameRole
Mr. Timothy SchmidExecutive Vice President & Worldwide Chairman of MedTech
Mr. Joaquin DuatoChief Executive Officer & Chairman
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D
Mr. Joseph J. Wolk CPAExecutive Vice President & Chief Financial Officer
NameRoleGenderDate of BirthPay
Mr. Timothy SchmidExecutive Vice President & Worldwide Chairman of MedTechMale19706.34M
Mr. Joaquin DuatoChief Executive Officer & ChairmanMale19635.9M
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative MedicineFemale19643.16M
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D19583.11M
Mr. Joseph J. Wolk CPAExecutive Vice President & Chief Financial OfficerMale19673.08M

Johnson & Johnson Insider Trades

Date1 May
NameREED JOHN C
RoleEVP, Innovative Medicine, R&D
TransactionAcquired
TypeM-Exempt
Shares25255
Date1 May
NameREED JOHN C
RoleEVP, Innovative Medicine, R&D
TransactionDisposed
TypeF-InKind
Shares11002
Date1 May
NameREED JOHN C
RoleEVP, Innovative Medicine, R&D
TransactionDisposed
TypeM-Exempt
Shares25255
Date24 Apr
NameWoods Eugene A.
RoleDirector
TransactionAcquired
TypeA-Award
Shares1316
Date24 Apr
NameWest Nadja
RoleDirector
TransactionAcquired
TypeA-Award
Shares1316
DateNameRoleTransactionTypeShares
1 MayREED JOHN CEVP, Innovative Medicine, R&DAcquiredM-Exempt25255
1 MayREED JOHN CEVP, Innovative Medicine, R&DDisposedF-InKind11002
1 MayREED JOHN CEVP, Innovative Medicine, R&DDisposedM-Exempt25255
24 AprWoods Eugene A.DirectorAcquiredA-Award1316
24 AprWest NadjaDirectorAcquiredA-Award1316

Discover More

Streamlined Academy

Johnson & Johnson

NYSE

Market Cap.

375.12B

Avg. Volume

9.67M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Johnson & Johnson News

Johnson & Johnson Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Johnson & Johnson Earnings & Revenue

Johnson & Johnson Income

Johnson & Johnson Balance Sheet

Johnson & Johnson Cash Flow

Johnson & Johnson Financials Over Time

Johnson & Johnson Executives

NameRole
Mr. Timothy SchmidExecutive Vice President & Worldwide Chairman of MedTech
Mr. Joaquin DuatoChief Executive Officer & Chairman
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D
Mr. Joseph J. Wolk CPAExecutive Vice President & Chief Financial Officer
NameRoleGenderDate of BirthPay
Mr. Timothy SchmidExecutive Vice President & Worldwide Chairman of MedTechMale19706.34M
Mr. Joaquin DuatoChief Executive Officer & ChairmanMale19635.9M
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative MedicineFemale19643.16M
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D19583.11M
Mr. Joseph J. Wolk CPAExecutive Vice President & Chief Financial OfficerMale19673.08M

Johnson & Johnson Insider Trades

Date1 May
NameREED JOHN C
RoleEVP, Innovative Medicine, R&D
TransactionAcquired
TypeM-Exempt
Shares25255
Date1 May
NameREED JOHN C
RoleEVP, Innovative Medicine, R&D
TransactionDisposed
TypeF-InKind
Shares11002
Date1 May
NameREED JOHN C
RoleEVP, Innovative Medicine, R&D
TransactionDisposed
TypeM-Exempt
Shares25255
Date24 Apr
NameWoods Eugene A.
RoleDirector
TransactionAcquired
TypeA-Award
Shares1316
Date24 Apr
NameWest Nadja
RoleDirector
TransactionAcquired
TypeA-Award
Shares1316
DateNameRoleTransactionTypeShares
1 MayREED JOHN CEVP, Innovative Medicine, R&DAcquiredM-Exempt25255
1 MayREED JOHN CEVP, Innovative Medicine, R&DDisposedF-InKind11002
1 MayREED JOHN CEVP, Innovative Medicine, R&DDisposedM-Exempt25255
24 AprWoods Eugene A.DirectorAcquiredA-Award1316
24 AprWest NadjaDirectorAcquiredA-Award1316

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - General
jnj.com

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Johnson & Johnson

Johnson & Johnson Financials

Table Compare

Compare JNJ metrics with:

   

Earnings & Growth

JNJ

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

JNJ

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

JNJ

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

JNJ

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Johnson & Johnson Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

5.0200

Payment DateDividendFrequency
2025-06-101.3Quarterly
2025-03-041.24Quarterly
2024-12-101.24Quarterly
2024-09-101.24Quarterly
2024-06-041.24Quarterly

Johnson & Johnson Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioNeutral
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)